Biolojic Design
We’re redefining what antibodies can do. CAPABILITIES Pioneering two new capabilities for natural human antibodies We leverage our platform to engineer epitope specific antibodies, such as agonists, antagonists, conformation-specific or conditional binders; or multibodies, which are multi-specific symmetrical IgG binding to more than one target on the same Fab. Biolojic’s multibodies will solve key challenges in
Basic Information
- Category: pharmaceutical industry
- Website: https://biolojic.com/
Documented Facts
- Inception (Wikidata): 2008-11 (Source 2: Wikidata Q138603508, revision 2470252276)
- Industry (Wikidata; date unspecified): pharmaceutical industry (Source 2: Wikidata Q138603508, revision 2470252276; Source 3: Wikidata label: Q507443, revision 2542338100)
- Legal form (Wikidata; date unspecified): limited company (Source 2: Wikidata Q138603508, revision 2470252276; Source 4: Wikidata label: Q33685, revision 2542684430)
- Country (Wikidata; date unspecified): Israel (Source 2: Wikidata Q138603508, revision 2470252276; Source 5: Wikidata label: Q801, revision 2557691295)
Evidence and Sources
- Biolojic Design — Official Site (official)
- Wikidata Q138603508, revision 2470252276 (knowledge-base)
- Wikidata label: Q507443, revision 2542338100 (knowledge-base)
- Wikidata label: Q33685, revision 2542684430 (knowledge-base)
- Wikidata label: Q801, revision 2557691295 (knowledge-base)
Citation Guidance
Explore pharmaceutical industry profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Biolojic Design.
- Canonical profile: https://brandsource.ai/brands/biolojic-design
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/biolojic-design/json-ld
- Citation profile API: https://brandsource.ai/api/brands/biolojic-design/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
We’re redefining what antibodies can do. CAPABILITIES Pioneering two new capabilities for natural human antibodies We leverage our platform to engineer epitope specific antibodies, such as agonists, antagonists, conformation-specific or conditional binders; or multibodies, which are multi-specific symmetrical IgG binding to more than one target on the same Fab. Biolojic’s multibodies will solve key challenges in
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 4 supporting sources linked.
- 4 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.